卵巢透明细胞腺癌在PET/CT上显示低68Ga-FAPI-46摄取和低18F-FDG摄取:一例病例报告
67岁女性,附件区12×20×24 cm肿瘤,超声提示不规则多房肿瘤、实性成分血流增多及腹水,符合卵巢癌表现。患者接受18F-FDG PET/CT和68Ga-FAPI-46 PET/CT,两者均显示低摄取值。组织病理学证实为卵巢透明细胞腺癌(OCCC),该亚型在FAPI PET/CT研究中代表性不足;低18F-FDG摄取是OCCC已知特征,但本例提示OCCC是68Ga-FAPI-46 PET/CT的潜在陷阱。
要点
- 卵巢透明细胞腺癌在18F-FDG PET/CT上可表现为低摄取,与既往报道一致。
- 本例卵巢透明细胞腺癌在68Ga-FAPI-46 PET/CT上也显示低摄取值。
- OCCC是68Ga-FAPI-46 PET/CT的潜在陷阱,该亚型在FAPI PET/CT研究中代表性不足。
核心结论
- 低18F-FDG摄取是卵巢透明细胞腺癌的已知特征且既往已有报道,但本例将OCCC识别为68Ga-FAPI-46 PET/CT的潜在陷阱。
研究设计与样本
- 病例报告:67岁女性,附件区12×20×24 cm肿瘤,接受18F-FDG PET/CT和68Ga-FAPI-46 PET/CT检查,并经组织病理学证实为卵巢透明细胞腺癌。
主要发现
- 超声显示不规则多房肿瘤,实性成分血流增多,并有腹水,符合卵巢癌表现。
- 18F-FDG PET/CT和68Ga-FAPI-46 PET/CT均显示低摄取值。
- 组织病理学证实为卵巢透明细胞腺癌,该亚型在FAPI PET/CT研究中代表性不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 67-year-old woman presented with a 12 × 20 × 24-cm adnexal tumor. Ultrasonography revealed an irregular, multilocular tumor, with increased flow in the solid components, and ascites-features that are consistent with ovarian cancer. The patient underwent 18 F-FDG PET/CT and 68 Ga-FAPI-46 PET/CT, both of which showed low uptake values. Histopathology confirmed ovarian clear cell adenocarcinoma (OCCC), a less common subtype that is underrepresented in FAPI PET/CT studies so far. Low 18 F-FDG uptake is a known feature of OCCC and has been previously reported; however, this case identifies OCCC as a potential pitfall in 68 Ga-FAPI-46 PET/CT.
引用
- Bentestuen M, Sylvest C, Frandsen AP, et al. Ovarian Clear Cell Adenocarcinoma With Low 68 Ga-FAPI-46 and Low 18 F-FDG Uptake on PET/CT : A Case Report. Clin Nucl Med. 2024. PMID: 39601076. doi:10.1097/RLU.0000000000005586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。